Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs
Open Access
- 1 May 2006
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 116 (5), 1371-1381
- https://doi.org/10.1172/jci27191
Abstract
Safe induction of autoantigen-specific long-term tolerance is the “holy grail” for the treatment of autoimmune diseases. In animal models of type 1 diabetes, oral or i.n. immunization with islet antigens induces Tregs that are capable of bystander suppression. However, such interventions are only effective early in the prediabetic phase. Here, we demonstrate that a novel combination treatment with anti-CD3ε–specific antibody and i.n. proinsulin peptide can reverse recent-onset diabetes in 2 murine diabetes models with much higher efficacy than with monotherapy with anti-CD3 or antigen alone. In vivo, expansion of CD25+Foxp3+ and insulin-specific Tregs producing IL-10, TGF-β, and IL-4 was strongly enhanced. These cells could transfer dominant tolerance to immunocompetent recent-onset diabetic recipients and suppressed heterologous autoaggressive CD8 responses. Thus, combining a systemic immune modulator with antigen-specific Treg induction is more efficacious in reverting diabetes. Since Tregs act site-specifically, this strategy should also be expected to reduce the potential for systemic side effects.Keywords
This publication has 41 references indexed in Scilit:
- Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitopeNature, 2005
- THE NOD MOUSE: A Model of Immune DysregulationAnnual Review of Immunology, 2005
- CD25+ CD4+ T Cells, Expanded with Dendritic Cells Presenting a Single Autoantigenic Peptide, Suppress Autoimmune DiabetesThe Journal of Experimental Medicine, 2004
- The Role of CD28 and CTLA4 in the Function and Homeostasis of CD4 + CD25 + Regulatory T CellsPublished by Wiley ,2003
- CD3-specific antibody-induced active tolerance: from bench to bedsideNature Reviews Immunology, 2003
- CD4+CD25+ Immunoregulatory T CellsImmunity, 2002
- Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-toleranceNature Immunology, 2002
- Heterodimeric CD3ϵγ extracellular domain fragments: production, purification and structural analysisJournal of Molecular Biology, 2000
- Intranasal Administration of Insulin Peptide B: 9–23 Protects NOD Mice from DiabetesAnnals of the New York Academy of Sciences, 1996
- Lessons Learned from Use of Cyclosporine for Insulin‐Dependent Diabetes MellitusAnnals of the New York Academy of Sciences, 1993